Polymer synthetic medical material for preventing postoperative celiac peritoneal adhesion

A peritoneal adhesion and polymer technology, applied in the field of polymer synthetic medical materials, can solve the problems of unsatisfactory anti-adhesion effect, short half-life, inability to maintain high drug concentration, etc. The effect of fibroblast proliferation

Inactive Publication Date: 2014-09-10
周广刚
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In the prior art, urokinase, fibrinolytic enzyme, sodium hyaluronate, etc. are often used to prevent peritoneal peritoneal adhesions. The disadvantages are that the half-life is short, and a high drug concentration cannot be maintained on the wound surface, and the anti-adhesion effect is not good. ideal

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0018] The components selected as raw materials and the parts by weight of each component are 10 parts by weight of berberine hydrochloride, 10 parts of menthol, 10 parts of Agrimony ethanol extract, and 40070 polyethylene glycol. Dissolve berberine hydrochloride, menthol, Agrimony ethanol extract in polyethylene glycol 400.

Embodiment 2

[0020] The components selected as raw materials and the parts by weight of each component are berberine hydrochloride 5, menthol 5, Agrimony ethanol extract 5, and polyethylene glycol 40085. Dissolve berberine hydrochloride, menthol, Agrimony ethanol extract in polyethylene glycol 400.

Embodiment 3

[0022] The components selected as raw materials and the parts by weight of each component are berberine hydrochloride 6, menthol 6, Agrimony ethanol extract 6, and polyethylene glycol 40082. Dissolve berberine hydrochloride, menthol, Agrimony ethanol extract in polyethylene glycol 400.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a polymer synthetic medical material for preventing postoperative celiac peritoneal adhesion. The polymer synthetic medical material comprises, by weight, 5-10 parts of berberine hydrochloride, 5-10 parts of menthol, 5-10 parts of hairyvein agrimony and 70-85 parts of polyethylene glycol.

Description

technical field [0001] The invention relates to a polymer synthetic medical material for preventing postoperative abdominal peritoneal adhesion. Background technique [0002] Abdominal peritoneal adhesion is a common complication of surgery, and the condition is prone to relapse, and reoperation may cause more serious adhesions. In the prior art, urokinase, fibrinolytic enzyme, sodium hyaluronate, etc. are often used to prevent peritoneal peritoneal adhesions. The disadvantages are that the half-life is short, and a high drug concentration cannot be maintained on the wound surface, and the anti-adhesion effect is not good. ideal. Contents of the invention [0003] The object of the present invention is to provide a polymer synthetic medical material for preventing postoperative abdominal peritoneal adhesions, which can effectively prevent abdominal peritoneal adhesions caused by surgery. [0004] Realize the technical scheme of the present invention: [0005] A polymer ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/73A61K47/34A61P41/00A61K31/045A61K31/4375
Inventor 周广刚高艳杰周游
Owner 周广刚
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap